S. D. Hytrek - Concepedia

Author

S. D. Hytrek

Also Known As

S. D. Hytrek, Staci D. Hytrek

Publications

200

Citations

H-Index

Concepts

All Affiliations

S. D. Hytrek is an author at Penn State Milton S. Hershey Medical Center specializing in oncology, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	200
2	Health Sciences	2	2	60
3	Cell Biology	2	2	69
4	Gastroenterology	1	1	46
5	Immunology	1	1	55

S. D. Hytrek

Publications

200

Citations

H-Index

Page 1

	Year	Citations
Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture Ian S. Zagon, S. D. Hytrek, Patricia J. McLaughlin American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Chemoprevention StrategyNative Opioid PeptidesColon Cancer CellsMedicinePharmacology	1996	55
Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice Ian S. Zagon, S. D. Hytrek, Jill P. Smith, Cancer Letters Pancreatic CancerNude MiceHuman GrowthMedicinePharmacology	1997	48
Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone S. D. Hytrek, Patricia J. McLaughlin, C. Max Lang, Cancer Letters Human Colon CancerMedicinePharmacologyGastroenterologyPharmacotherapy	1996	46
Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer Ian S. Zagon, S. D. Hytrek, Chao Lang, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Tumor BiologyOncologyChemoprevention StrategyHuman Colon CancerMedicine	1996	37
Identification and characterization of zeta-opioid receptor in human colon cancer S. D. Hytrek, Jill P. Smith, Thomas J. McGarrity, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology PathologyPharmacotherapyReceptor Tyrosine KinaseAnti-cancer AgentSingle Binding Site	1996	14

Page 1